Clinical Equipoise in the Management of Patients with Femoroacetabular Impingement Syndrome and Concomitant Tönnis Grade 2 or Greater Hip Osteoarthritis: An International Expert-Panel Delphi Study.

Consensus Delphi FAIS Femoroacetabular Impingement Syndrome Level of Evidence: Expert opinion Level of evidence V

Journal

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
ISSN: 1526-3231
Titre abrégé: Arthroscopy
Pays: United States
ID NLM: 8506498

Informations de publication

Date de publication:
27 Dec 2023
Historique:
received: 27 05 2023
revised: 17 12 2023
accepted: 19 12 2023
medline: 2 1 2024
pubmed: 2 1 2024
entrez: 29 12 2023
Statut: aheadofprint

Résumé

To gather global-expert opinion for the management of patients with femoroacetabular impingement syndrome (FAIS) and Tönnis grade 2 or greater hip osteoarthritis (OA). An internet-based modified Delphi methodology was used via an online platform (Online Surveys UK). The expert panel comprised 27 members from 18 countries: 21 (78%) orthopaedic surgeons, 5 (18%) physiotherapists and 1 (4%) dual orthopaedic surgeon and sport and exercise medicine physician. Comments and suggestions were collected during each round and amendments were performed for the subsequent round. Between each round, the steering panel provided the experts with a summary of results and amendments. Consensus was set a priori as a minimum agreement of 80%. A complete participation (100%) was achieved in all four rounds . A final list of 10 consensus statements was formulated. Experts agreed that there is no single superior management strategy for FAIS with Tönnis stage 2 OA and that Tönnis stage 3 OA and the presence of bilateral cartilage defects (acetabular and femoral) is a contraindication for hip preservation surgery. Non-operative management should include activity modification and physiotherapy with hip-specific, lumbo-pelvic and core strengthening. There was no consensus for the need of three-dimensional imaging for initial quantification of joint degeneration. There is clinical equipoise in terms of the best management strategy for patients with FAIS and Tönnis stage 2 OA and therefore, there is a need for performing a randomized controlled trial for this cohort with differing management strategies.

Identifiants

pubmed: 38158166
pii: S0749-8063(23)01014-9
doi: 10.1016/j.arthro.2023.12.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Octavian Andronic (O)

Department of Orthopaedics, Balgrist University Hospital, University of Zürich, Forchstrasse 340, 8008 Zürich, Switzerland; Medical Technology Research Centre, Anglia Ruskin University, Bishop Hall Lane, Chelmsford CM1 1SQ, United Kingdom; Young Adult Hip Service, Department of Trauma and Orthopaedics, Box 37, Hills Road, Addenbrooke's - Cambridge University Hospital, Cambridge CB2 0QQ, United Kingdom. Electronic address: octavian.andronic@balgrist.ch.

Victor Lu (V)

School of Clinical Medicine, University of Cambridge, CB2 0SP, United Kingdom.

Leica Sarah Claydon-Mueller (LS)

Medical Technology Research Centre, Anglia Ruskin University, Bishop Hall Lane, Chelmsford CM1 1SQ, United Kingdom.

Rachael Cubberley (R)

Medical Technology Research Centre, Anglia Ruskin University, Bishop Hall Lane, Chelmsford CM1 1SQ, United Kingdom.

Vikas Khanduja (V)

Medical Technology Research Centre, Anglia Ruskin University, Bishop Hall Lane, Chelmsford CM1 1SQ, United Kingdom; Young Adult Hip Service, Department of Trauma and Orthopaedics, Box 37, Hills Road, Addenbrooke's - Cambridge University Hospital, Cambridge CB2 0QQ, United Kingdom. Electronic address: vk279@cam.ac.uk.

Classifications MeSH